Close

Anti-VSV Peptide T cell receptor ((N30.7 TCRα)-3), pCDTCR1 (TCR-YC1363)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

It was created a transgenic mouse that expressed exclusively the TCR α-chain of a VSV-specific, H-2Kb-restricted T cell clone (N30.7, Vα2/Vβ13). When the transgenic mice were immunized with the VSV peptide, Vβ13 was again the predominant Vβ element present in VSV-specific CTL populations. However, the TCR Vβ usage was profoundly altered when these transgenic mice were immunized with peptides carrying single replacements near the C terminus of VSV. Peptides with replacements at the N terminus of VSV were able to induce a strong cytotoxic response but did not alter the TCR Vβ usage.

Specific Inquiry

  • Size:
  • Marker:
  • Form:
  Add to Cart

Details

  • Target
  • VSV Peptide
  • Epitope
  • RGYVYDGL
  • Format
  • Non-Modified TCR
  • Allele
  • H2-Kb
  • Vector Name
  • pCDTCR1
  • Vector Length
  • ~ 8 kb
  • Vector Type
  • Lentiviral vector
  • TCR Clone
  • N30.7 TCRα
  • Host Species
  • Mouse

Target

  • Introduction
  • The VSV peptide, corresponding to residues 52–59 from the nucleocapsid of the vesicular stomatitis virus, binds to H-2Kb, triggering a strong immune response mediated by cytotoxic CD8+ T cells. Previous analysis of VSV-specific CTL clones revealed the preferential usage of the Vβ13 and Vβ8 elements. Functional studies and analysis of the crystal structure of the H-2Kb/VSV complex have allowed the potential TCR-contact residues of the VSV peptide to be identified. In the present work, we asked how single amino acid replacements in TCR-exposed positions of the VSV peptide would affect the TCR repertoire of the responding CD8+ T cell population.

Customer Reviews and Q&As

There are currently no customer reviews or questions for Mouse anti-VSV Peptide T cell receptor ((N30.7 TCRα)-3), pCDTCR1 (TCR-YC1363). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.